Chronic testosterone administration improves cardiac contractility and has a beneficial effect on the haemostatic system by enhancing fibrinolytic activity and inducing hypocoagulation in healthy rats

References

• Agledahl, I., et al., 2008. Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study. Nutrition, metabolism, and cardiovascular diseases, 18, 256–262.
   PubMed Web of Science ®Google Scholar
• Ajayi, A.A., Mathur, R., and Halushka, P.V., 1995. Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation, 91, 2742–2747.
   PubMed Web of Science ®Google Scholar
• Anderson, R.A., Ludlam, C.A., and Wu, F.C., 1995. Haemostatic effects of supraphysiological levels of testosterone in normal men. Thrombosis and haemostasis, 74 (2), 693–697.
   PubMed Web of Science ®Google Scholar
• Angelakos, E.T., King, M.P., and Millard, R.W., 1969. Regional distribution of catecholamines in the hearts of various species. Annals of the New York Academy of Sciences, 156, 219–240.
   PubMed Web of Science ®Google Scholar
• Bachman, E., et al., 2014. Testosterone induces erythrocytosisvia increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin setpoint. The journal of gerontology. Series A, biological sciences and medical sciences, 69, 725–735.
   PubMed Web of Science ®Google Scholar
• Bavenholm, P., et al., 1998. Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function. European heart journal, 19, 402–410.
   PubMed Web of Science ®Google Scholar
• Beguin, S., et al., 1992. The mode of action of CY216 and CY222 in plasma. Thrombosis and haemostasis, 67, 33–41.
   PubMed Web of Science ®Google Scholar
• Campelo, A.E., Cutini, P.H., and Massheimer, V.L., 2012. Testosterone modulates platelet aggregation and endothelial cell growth through nitric oxide pathway. The journal of endocrinology, 213, 77–87.
   PubMed Web of Science ®Google Scholar
• Campo, G., et al., 2006. Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. Arteriosclerosis, thrombosis, and vascular biology, 26, 2800–2806.
   PubMed Web of Science ®Google Scholar
• Chan, M.Y., Andreotti, F., and Becker, R.C., 2008. Hypercoagulable states in cardiovascular disease. Circulation, 118, 2286–2297.
   PubMed Web of Science ®Google Scholar
• Cutini, P.H., et al., 2012. The role of sex steroids on cellular events involved in vascular disease. The journal of steroid biochemistry and molecular biology, 132, 322–330.
   PubMed Web of Science ®Google Scholar
• De Pergola, G., et al., 1997. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men. Metabolism: clinical and experimental, 46, 1287–1293.
   PubMed Web of Science ®Google Scholar
• Dejana, E., et al., 1979b. Bleeding time in laboratory animals. III – do tail bleeding times in rats only measure a platelet defect? (The aspirin puzzle). Thrombosis research, 15, 199–207.
   PubMed Web of Science ®Google Scholar
• Dejana, E., Villa, S., and de Gartano, G., 1979a. Bleeding time in rats: a comparison of different experimental conditions. Thrombosis research, 15, 191–197.
   PubMed Web of Science ®Google Scholar
• Doggen, C.J., Rosendaal, F.R., and Meijers, J.C., 2006. Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII. Blood, 108, 4045–4051.
   PubMed Web of Science ®Google Scholar
• Ernst, E., and Koenig, W., 1997. Fibrinogen and cardiovascular risk. Vascular medicine (London, England), 2, 115–125.
   PubMedGoogle Scholar
• Farhat, M.Y., Lavigne, M.C., and Ramwell, P.W., 1996. The vascular protective effects of estrogen. FASEB journal, 10, 615–624.
   PubMed Web of Science ®Google Scholar
• Gale, A., 2011. Continuing education course #2: current understanding of hemostasis. Toxicologic pathology, 39, 273–280.
   PubMed Web of Science ®Google Scholar
• Glueck, C.J., et al., 1993. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men. Journal of laboratory and clinical medicine, 122, 412–420.
   PubMed Web of Science ®Google Scholar
• Golden, K.L., marsh, J.D., and jiang, Y., 2004. Testosterone regulates mRNA levels of calcium regulatory proteins in cardiac myocytes. Hormone and metabolic research, 36, 197–202.
   PubMed Web of Science ®Google Scholar
• Golden, K.L., marsh, J.D., and Jiang, Y., 2005. Acute actions of testosterone on contractile function of isolated rat ventricular myocytes. European journal of endocrinology, 152, 479–483.
   PubMed Web of Science ®Google Scholar
• Golomb, M.R., Dick, P.T., and MacGregor, D.L., 2004. Neonatal arterial ischemic stroke and cerebral sinovenous thrombosis are more commonly diagnosed in boys. Journal of child neurology, 19, 493–497.
   PubMed Web of Science ®Google Scholar
• Golomb, M.R., et al., 2009. Male predominance in childhood ischaemic stroke and cerebral sinovenous thrombosis: findings from the international pediatric stroke study. Stroke, 40, 52–57.
   PubMed Web of Science ®Google Scholar
• Haddad, R., et al., 2007. Testosterone and cardiovascular risk in men: a systemic review and meta-analysis of randomized placebo-controlled trials. Mayo clinic proceedings, 81, 29–39.
   Google Scholar
• Hak, A.E., et al., 2002. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. The journal of clinical endocrinology and metabolism, 87, 3632–3639.
   PubMed Web of Science ®Google Scholar
• Harrison, P., 2009. Assessment of platelet function in the laboratory. Hämostaseologie, 29, 25–31.
   PubMed Web of Science ®Google Scholar
• Hemker, H.C., and Be´guin, S., 1995. Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thrombosis and haemostasis, 74, 134–138.
   PubMed Web of Science ®Google Scholar
• Hoffman, C.J., et al., 1989. Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease. Journal of the American college of cardiology, 14, 941–946.
   PubMed Web of Science ®Google Scholar
• Isidori, A.M., et al., 2005. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clinical endocrinology, 63, 280–293.
   PubMed Web of Science ®Google Scholar
• Jansson, I.H., Nilsson, T.K., and hnson, O., 1991. Von Wille brand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. British heart journal, 66, 351–355.
   PubMedGoogle Scholar
• Jin, H., et al., 2007. Physiological testosterone stimulates tissue plasminogen activator and tissue factor pathway inhibitor and inhibits plasminogen activator inhibitor type 1 release in endothelial cells. Biochemistry and cell biology, 85, 246–251.
   PubMed Web of Science ®Google Scholar
• Jones, R.D., et al., 2003. The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action? British journal of pharmacology, 138, 733–744.
   PubMed Web of Science ®Google Scholar
• Juhan-Vague, I., et al., 1996. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation, 94, 2057–2063.
   PubMed Web of Science ®Google Scholar
• Khaw, K.T., Dowsett, M., and Folkerd, E., 2007. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study. Circulation, 116, 2694–2701.
   PubMed Web of Science ®Google Scholar
• Kluft, C., et al., 1985. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scandinavian journal of clinical and laboratory investigation, 45, 605–610.
   PubMed Web of Science ®Google Scholar
• Koenig, W., 1998. Haemostatic risk factors for cardiovascular disease. European heart journal, 19, C39–C43.
   PubMed Web of Science ®Google Scholar
• Koepke, J.A., 1986. Partial thromboplastin time test-proposed performance guidelines. ICSH Panel on the PTT. Thrombosis and haemostasis, 55, 143– 144.
   PubMed Web of Science ®Google Scholar
• Lane, D.A., and Grant, P.J., 2000. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood, 95, 1517–1532.
   PubMed Web of Science ®Google Scholar
• Laughlin, G.A., Barrett-Connor, E., and Bergstrom, J., 2008. Low serum testosterone and mortality in older men. The journal of clinical endocrinology and metabolism, 93, 68–75.
   PubMed Web of Science ®Google Scholar
• Liu, P.Y., Death, A.K., and Handelsman, D.J., 2003. Androgens and cardiovascular disease. Endocrine reviews, 24, 313–340.
   PubMed Web of Science ®Google Scholar
• Malkin, C.J., Pugh, P.J., and West, J.N., 2006. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. European heart journal, 27, 57–64.
   PubMed Web of Science ®Google Scholar
• Marquardt, R., 1979. Effect of dopamine and metaproterenol on serum free fatty acids in regard to induction of cardiac arrhythmia. Die medizinische welt, 30, 707–708.
   PubMed Web of Science ®Google Scholar
• Marsh, J.D., et al., 1998. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation, 98, 256–261.
   PubMed Web of Science ®Google Scholar
• Meydan, S., et al., 2010. Effects of testosterone on orchidectomy-induced oxidative damage in the rat hippocampus. Journal of chemical neuroanatomy, 40, 281–285.
   PubMed Web of Science ®Google Scholar
• Mitropoulos, K.A., 1988. Hypercoagulability and factor VII in hypertriglyceridemia. Seminars in thrombosis and hemostasis, 14, 246–252.
   PubMed Web of Science ®Google Scholar
• Nettleship, J.E., et al., 2009. Testosterone and coronary artery disease. Frontiers of hormone research, 37, 91–107.
   PubMed Web of Science ®Google Scholar
• Nieuwenhuys, C.M., et al., 1998. Hypocoagulant and lipid-lowering effects of dietary n-3 polyunsaturated fatty acids with unchanged platelet activation in rats. Arteriosclerosis, thrombosis, and vascular biology, 18, 1480–1489.
   PubMed Web of Science ®Google Scholar
• Pawlowitzki, I.C.H., Diekstall, P., Ming, P., and Balleisen, L., 1986. Abnormal platelet function in Kallman syndrome. Lancet, 8499, 166.
   Google Scholar
• Phillips, G.B., Pinkernell, B.H., and Jing, T.Y., 1994. The association of hypotestosteronemia with coronary artery disease in men. Arteriosclerosis and thrombosis, 14, 701–706.
   PubMed Web of Science ®Google Scholar
• Pilo, R., Aharony, D., and Raz, A., 1981. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid and metabolism. Thrombosis and haemostasis, 46, 538–542.
   PubMed Web of Science ®Google Scholar
• Pop, G.A.M., et al., 2002. The clinical significance of whole blood viscosity in (cardio)vascular medicine. Netherlands heart journal, 10, 512–516.
   PubMedGoogle Scholar
• Quick, A.J., 1935. The prothrombin time in hemophilia and in obstructive jaundice. Journal of biological chemistry, 109, 73–74.
   Google Scholar
• Quigley, R., 2008. Androgens stimulate proximal tubule transport. Gender medicine, 5(Suppl A), S114–S120.
   PubMedGoogle Scholar
• Reshmi, S., Faraday, N., and Dobs, A., 2014. Testosterone and arterial thrombosis. Journal of endocrinology, diabetes & obesity, 2, 1041.
   Google Scholar
• Rodak, B.F., 2002. Hematology, clinical principles and applications. 2nd ed. Philadelphia: W.B Saunders, 609–753.
   Google Scholar
• Rosano, G.M.C., et al., 1999. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation, 99, 1666–1670.
   PubMed Web of Science ®Google Scholar
• Saldeen, P., Nilsson, I.M., and Saldeen, T., 1983. Increased synthesis of thromboxane B2 and 6-keto-PGF1 alphas in hand veins from patients with deep venous thrombosis. Thrombosis research, 32, 461–467.
   PubMed Web of Science ®Google Scholar
• Shatoor, A.S., et al., 2012. Effect of Hawthorn (Crataegus aronia syn. Azarolus (L)) on platelet function in albino Wistar rats. Thrombosis research, 130, 75–80.
   PubMed Web of Science ®Google Scholar
• Stella, L., Donati, M.B., and de Gaetano, G., 1975. Bleeding time in laboratory animals. I. Aspirin does not prolong bleeding time in rats. Thrombosis research, 7, 709–716.
   PubMed Web of Science ®Google Scholar
• Tracy, R.P., 1997. Atherosclerosis, thrombosis and inflammation: a question of linkage. Fibrinolysis proteol, 11, 137–142.
   Google Scholar
• Tracy, R.P., and Bovill, E. G., 1995. Hemostasis and risk of ischemic disease: epidemiological evidence with emphasis on the elderly. In: R. Califf, D. Mark, G. Wagner, eds. Acute coronary care in the thrombolytic era. St Louis, MO: Mosby-Year Book, Inc, 27–43.
   Google Scholar
• Viallard, J.F., Marit, G., and Mercie, P., 2000. Polycythaemia as a complication of transdermal testosterone therapy. British journal of haematology, 110, 237–238.
   PubMed Web of Science ®Google Scholar
• Webb, C.M., et al., 1999. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation, 100, 1690–1696.
   PubMed Web of Science ®Google Scholar
• Whitsel, E.A., et al., 2001. Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis. The American journal of medicine, 111, 261–269.
   PubMed Web of Science ®Google Scholar
• Winkler, U.H., 1996. Effects of androgens on haemostasis. Maturitas, 24, 147–155.
   PubMed Web of Science ®Google Scholar
• Yildiz, O., and Seyrek, M., 2007. Vasodilating mechanisms of testosterone. Experimental and clinical endocrinology & diabetes, 115, 1–6.
   PubMed Web of Science ®Google Scholar
• Yu, C., et al., 2014. Effects of danshensu on platelet aggregation and thrombosis: in vivo arteriovenous shunt and venous thrombosis models in rats. PLoS One, 9, e110124.
   PubMed Web of Science ®Google Scholar